Round 75, 76 and 77 have been one long round. In order to keep accurate track, I split the one LONG round into the equivalent number of hours his usual round lasts. We were able to do three rounds worth of chelating during spring break!
One Heart, One Mind: The Case for Healing Autism – A New Book by Pierre Fontaine CCH
RecoveringNicholas’s homeopath, Pierre Fontaine, has published a new book titled, “One Heart, One Mind – The Case for Healing Autism” which takes a look at several of his cases in which he recovered children from autism. He’s shared this book with me so that I can share it with all of you. It has been […]
Phenomenal Autism & PANDAS Recovery in Progress thanks to Classical Homeopath Pierre Fontaine!!
Pierre Fontaine has shared a new case and the results have been phenomenal! DOB: 1/15/2008 ASD / PANDAS During pregnancy Mom was sick (nauseous), had sun poisoning, was Strep B positive and had to take a high dose of penicillin before birth. Parents were stressed (selling home and building a new one). Dad had just […]
Update on Nicholas – Coming up on our 4 Year Anniversary with Homeopathy and Pierre Fontaine!!
To those of you who have emailed to check up on us, thanks so much – its so nice to hear from those of you who are still fighting so vigilantly to heal your children from autism, aspergers and adhd!! I hope that you all find the path to recovering your child! Nicholas continues to […]
Living life… autism-free!!
Thank you all for the emails inquiring about Nicholas. We’re all doing great and continue to be ecstatic with his progress with homeopathy! Autism took away so much of our lives for too long, as I am sure you can imagine… whether it’s one day or three years, it’s all too long when you are […]
Interview with Pierre Fontaine: Homeopathy & Autism
June 4th, Pierre Fontaine joined me live on Biomed for Autism’s radio show to discuss classical homeopathy for children with autism. You can listen to the archive here: http://www.blogtalkradio.com/biomed-for-autism/2010/06/04/classical-homeopathy-with-pierre-fontaine Visit the Biomed for Autism Facebook page to keep up on future events! Pierre Fontaine, RSHom (NA), CCH, has been a professional Homeopath in New York […]
Current Master Supplement List: April 2010
April 1st, 2010 
Mom Note: For info on these supplements including where to buy them, visit my Supplement Directory page.
Changes since the last update are:
stopped Cytoflora (did not lose gains, would revisit in the future to see if we got another language boost if necessary) dropped Swanson’s Magnesium Complex dropped AMLA dropped Wild Oregano Oil dropped UBQH as I ran out of it and forgot to reorder, so I decided to see if I saw any decline in any area, which I have not.
Vitamins & Minerals
Lee Silsby ASD Pure Vitamin/Mineral formula – 6 Capsules per day
MB-12 Injections
BioTech Vitamin D3 (cholecalciferol) – 5000 IU
Swanson Vitamin E Mixed Tocopherols – 800 IU
Klaire’s Micellized vitamin A – 5 drops per day
Swanson Vitamin C – 3-4 caps per day
Swanson Biotin – 5mg caps 3 caps per day
Kirkman Zinc – 20mg – 2 caps at night
Omega Fish Oil / Cod Liver Oil / Essential Oils & Fatty Acids
Nordic Naturals Complete Omega 3-6-9 – 3 gelcaps
Organic Coconut Oil softgels – 1 soft gel per day
Probiotics & Prebiotics
Culturelle – 2 capsules per day
Klaire Detox Probiotic – 2 capsules per day
Anti-fungals & Anti-bacterials, Anti-Virals, yeast-fighting, etc.
Enhansa from Lee Silsby – 1800mg per day — give No-Fenol with Enhansa if child has phenol issues (red cheeks/ears)
Enzymes
Houston Nutraceuticals No Phenol – given with Enhansa only now
Houston Nutraceuticals Tri-Enza – with meals
For the liver
Liver life (2 dropperfuls per day)
For constipation
Oxypowder – (to keep his bowels moving) – only as needed (this stuff is fantastic!)
Other
4Life Transfer Factor Tri-Factor Formula – 200mg – 2 capsules 3x per day
Georges Always Active 100% Aloe Vera – about 2-4 ounces per day
Round 76: Complete
April 1st, 2010 Mom Round 76 Completed.
Since Nicholas is on Spring Break this week, I’ve extended Round 75. In order to keep the number of rounds straight, I’m splitting them into the number of hours his usual rounds last.
He’s been great so far on the longer round. We tried this in the past and had to end the round, but this time, things are different.
Merck KGaA halts cancer vaccine trial
March 25th, 2010 Mom What’s always so amazing to me is the utter denial that childhood vaccines can harm our children BUT a patient contracted encephalitis (brain inflammation) during a vaccine trial and they halt the program. In case you didn’t know, a huge percentage of our children suffer from brain inflammation.
Merck KGaA halts cancer vaccine trial
By Steve Goldstein, MarketWatch
LONDON (MarketWatch) — Merck KGaA on Tuesday said it’s halting trials of a cancer vaccine after a patient contracted a brain disease.Darmsteadt, Germany-based Merck /quotes/comstock/11e!fmrk (DE:MRK 59.21, -0.09, -0.15%) said it’s temporarily suspending its clinical program for Stimuvax after a patient in Phase II trials taking the vaccine in combination with a low-dose chemotherapy drug called cyclophosphamide contracted encephalitis, which is a form of rare brain inflammation.
The U.S. Food and Drug Administration has also put a clinical hold on Stimuvax, which is licensed from Seattle-based Oncothyreon /quotes/comstock/15*!onty/quotes/nls/onty (ONTY 3.42, -0.07, -2.01%) .
“We understand that Merck Serono is working closely with the FDA, other regulatory agencies and the patient’s physicians to evaluate the implications of this adverse reaction and to determine an appropriate course of action,” said Oncothyreon CEO Robert Kirkman.
Merck, unrelated to the American drug maker of the same name, noted that other Stimuvax studies are not used with the same intensity of cyclophosphamide.
It said the move was a “precautionary” one while it studies the “adverse event.”
Though the affected patient was using the vaccine due to multiple myeloma, Merck said late-stage trials for non-small cell lung cancer and breast cancer also are impacted.
Shares of Merck dropped 0.8% in afternoon Frankfurt trade, and the company’s stock has lost about 6% of its value over the last year.
“We have never included a [net present value] for the product in our valuation and would expect the market to have been cautious as well. Nevertheless, expect some pressure on the stock today as a result of this news,” said analysts at WestLB of Merck.
For Oncothyreon, the reaction was more severe — shares plummeted 28% in early trade.
Steve Goldstein is MarketWatch’s London bureau chief.
and
Merck KGaA halts cancer trial after brain inflammation case
23 March 2010
Shares in Merck KGaA have slipped this morning after the German firm suspended a mid-stage trial of its cancer vaccine Stimuvax after a patient suffered an “unexpected serious adverse reaction”, ie encephalitis.The Darmstadt-based company noted that one of 30 patients participating in a Phase II trial of the vaccine in patients with multiple myeloma developed encephalitis, or acute inflammation of the brain. The patient received the vaccine (licensed from the USA’s Oncothyreon) in combination with “an intensified schedule of low-dose cyclophosphamide, which is not used in the other Stimuvax studies”. Merck noted that it has now stopped recruitment and treatment of patients in all studies of the vaccine, including the Phase III non-small-cell lung cancer trials called START and INSPIRE, as well as the late-stage STRIDE study in patients with breast cancer.
The company says it will work closely with the regulatory authorities, particularly with the US Food and Drug Administration (which has placed a clinical hold on the Investigational New Drug application for Stimuvax) “to evaluate the implications of the adverse reaction on the clinical development programme” for the vaccine “and determine the most suitable course of action”. Merck added that the move is a precautionary measure as it finds out what caused the patient to contract encephalitis – indeed some patients have been taking Stimuvax for eight years without any serious problems.
Some analysts are fearing the worst, however. Andrew Baum at Morgan Stanley issued a research note saying that the suspension of the clinical programme for Stimuvax “constitutes another blow to the company’s pipeline”, coming as it does on the back of regulatory rejections for Erbitux (cetuximab) as a treatment for advanced lung cancer. Merck also received a ‘refuse to file’ letter from the FDA for its oral multiple sclerosis drug cladribine in November last year, though it should be noted that regulators on this side of the Atlantic were satisfied with the submission and are reviewing the pill.
Richard Parkes at Piper Jaffray wrote that “we are surprised at such a swift decision to halt recruitment based on a single case of encephalitis, and it remains possible that other less severe signals of neurological adverse events may have contributed to the decision”.
By Kevin Grogan
The Truth About Gardasil
March 24th, 2010 Mom This presentation was presented to the FDA, on Friday, March 12 in the form of a power point presentation. Each member in the group also received a file containing with over 236 pages of research, data and parental concerns.
http://truthaboutgardasil.org/wp-content/themes/city-thunder/ppt/030610FDApresentation.pdf
If you’re thinking of giving these to your daughter, please reconsider. Your daughter’s life is worth more than the risk here.
Rotarix rotavirus vaccine contaminated, officials say
March 23rd, 2010 Mom Rotarix rotavirus vaccine contaminated, officials say
By Tom Watkins, CNNMarch 22, 2010 — Updated 2022 GMT (0422 HKT)
http://edition.cnn.com/2010/HEALTH/03/22/rotavirus.vaccine/index.html
(CNN) — Federal health authorities recommended Monday that doctors suspend using Rotarix, one of two vaccines licensed in the United States against rotavirus, saying the vaccine is contaminated with material from a pig virus.
“There is no evidence at this time that this material poses a safety risk,” Food and Drug Administration Commissioner Dr. Margaret Hamburg told reporters in a conference call.
Rotarix, made by GlaxoSmithKline, was approved by the FDA in 2008. The contaminant material is DNA from porcine circovirus 1, a virus from pigs that is not known to cause disease in humans or animals, Hamburg said.
About 1 million children in the United States and about 30 million worldwide have gotten Rotarix vaccine, she said.
Rotavirus disease kills more than 500,000 infants around the world each year, primarily in low- and middle-income countries, she said. Before rotavirus vaccine became available, the disease was blamed for more than 50,000 hospitalizations and several dozen deaths per year in the United States, she said.
The FDA learned about the contamination after an academic research team using a novel technique to look for viruses in a range of vaccines found the material in GlaxoSmithKline’s product and told the company, Hamburg said. The drug maker confirmed its presence in both the cell bank and the seed from which the vaccine is derived, suggesting its presence from the early stages of vaccine development, she said. The FDA then confirmed the drug maker’s findings.
GlaxoSmithKline emphasized Monday that the pig virus is not known to cause illness in humans, saying “it is found in everyday meat products and is frequently eaten with no resulting disease or illness.”
“No safety issue has been identified by external agencies or GSK,” Thomas Breuer, the drug maker’s chief medical officer, said in a written statement. “GSK is committed to patient safety and to the highest manufacturing standards for all our vaccines and medicines. We are already working closely and discussing this finding with regulatory agencies around the world.”
Another vaccine, RotaTeq, is made by Merck and was approved in 2006. There is no evidence that the Merck product is affected, Hamburg said. Both vaccines are given by mouth to infants to prevent rotavirus disease, which is marked by severe diarrhea and dehydration.
Asked whether Merck would be able to meet the nation’s demand, Merck spokeswoman Pam Eisele said, “Obviously, we will work with the … FDA to evaluate supply needs.”
In the next four to six weeks, the drug agency will convene an advisory committee to make recommendations and seek input on the use of new techniques for identifying viruses in vaccine, Hamburg said.
“We’re not pulling it from the market, we’re just suspending its use during this period while we’re collecting more information,” she said. “It should not be in this vaccine product and we want to understand how it got there. It’s not an easy call and we spent many long hours debating the pros and cons but, because we have an alternative product and because the background rates of this disease are not so severe in this country, we felt that the judicious thing to do was to take a pause, to really ask the critical questions about what this material was doing in the vaccine, how it got there.”
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, said “a substantial amount” of the DNA was found in the vaccine. But, he stressed, “there is no evidence that it causes any disease. … There is no evidence that it ever does anything.”
The research group that discovered the contamination has asked not to be identified pending its paper’s publication in a scientific journal, Hamburg said.
Anyone who has already received a dose of Rotarix should switch to the Merck product for the next two doses, Hamburg said. Preliminary testing of the Merck product has found no evidence of the porcine circovirus 1 DNA, she said. Doctors should be able to tell parents which of the two products their children received, she said.
Hamburg stressed that the suspension applies only to the United States. Public health officials in countries where the incidence of rotavirus is more severe may decide that the benefits of continuing to use the vaccine outweigh any concerns raised by the contamination, she said. “Such a decision would be very understandable,” she added.
A similar virus, porcine circovirus 2, also does not cause disease in humans, but it does cause disease in its pig host, Hamburg said.
New Warning About Everyday Poison Linked to Alzheimer’s, ADHD, and Autism
March 23rd, 2010 Mom Dr. Ayoub has identified one vaccine in particular as being one of the absolute worst in terms of aluminum content – Pediatrix. It’s a combination vaccine, which contains 850 mcg of elemental aluminum. This interview is worth listening to:
American Diabetes Association peddling nutritional nonsense while accepting money from manufacturer of candy and sodas
March 23rd, 2010 Mom American Diabetes Association peddling nutritional nonsense while accepting money from manufacturer of candy and sodas
http://www.naturalnews.com/008164_American_Diabetes_Association_the_ADA.html
“Diabetics who drink large amounts of aspartame-sweetened drinks are more likely to go blind. Aspartame is composed of the excitotoxin aspartic acid, methanol (also a known eye toxin) and the amino acid phenylalanine. Given this evidence, then, why do the American Diabetes Association and thousands of doctors encourage their diabetic patients to use aspartame? At least where the American Diabetes Association is concerned, it may have something to do with the fact that the organization has received large monetary contributions from Monsanto, the manufacturer of NutraSweet®!”
High Dose Vitamin A Protocol – 3rd Round
March 22nd, 2010 Mom We just completed the 2 Day High Dose Vitamin A Protocol for the third time. It always seems like we get some good gains afterward, but I must admit I am a little disappointed that we haven’t seen anything major happen. I should run his measles titers and see if they have come down any. At this time, I am not sure if I will be doing a 4th round of this protocol.
